NCT00421135View on ClinicalTrials.gov

A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Advanced Cancer
Interventions
DRUG

ZIO-201

ZIO-201 as a single dose given once every 21 days. This is a dose escalation arm.

Trial Locations (2)

Unknown

Santa Monica

Detroit

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY